Surgery Helped Stop Seizures In Children After Brain Injury
This study looked at hemispherotomy, a surgery that disconnects one side of the brain, in children with drug-resistant epilepsy that developed after a traumatic brain injury.
This hub covers drug-resistant epilepsy: When seizures aren’t controlled after trying two appropriate medicines. Research-backed next steps on diet therapies, devices, surgery evaluation, and safety.
If seizures aren’t controlled after two meds, it’s worth at least an evaluation at an epilepsy center.
Not necessarily. Some familiar consider it earlier depending on seizure type and goals.
Yes. Treatment response can change over time, and combinations/approaches matter.
Seizure frequency, triggers, sleep, missed meds, side effects, and rescue med use.
This study looked at hemispherotomy, a surgery that disconnects one side of the brain, in children with drug-resistant epilepsy that developed after a traumatic brain injury.
This study asked a panel of 28 stakeholders from European Union countries and the UK to give their views about what “seizure freedom” should mean in epilepsy care and research, and why it matters.
This study looked at whether a brain signal called slow gamma activity in the anterior nucleus of the thalamus (ANT) might help indicate whether deep brain stimulation (DBS) is working for people with drug-resistant epilepsy.
This study looked at fenfluramine, a seizure medicine, in children and adults with developmental and epileptic encephalopathies (DEEs).
Researchers studied cannabidiol (CBD) in a lab rat model of malformation of cortical development (MCD), a brain development problem linked to hard-to-treat epilepsy.
This study looked at children with a rare brain abnormality called focal cortical dysplasia type 1 (FCD1), which can cause epilepsy that does not respond to medicine.
This study looked at add-on treatment with perampanel in very young children with drug-resistant epilepsy.
This study tested ES-481, a new add-on anti-seizure medicine, in adults with drug-resistant epilepsy.
Researchers combined results from randomized, double-blind studies that tested two add-on seizure medicines, lacosamide (LCM) and brivaracetam (BRV), in adults and older teens with drug-resistant focal epilepsy.